Sign In
Buy VECT
$16.85
+0 (+0%)
At Close: Oct 06, 2023
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
08:30am, Thursday, 29'th Jun 2023
BOSTON & BASEL, Switzerland--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT)
Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio
07:00am, Friday, 16'th Jun 2023
BOSTON & BASEL, Switzerland--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT)
Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround
09:54am, Monday, 12'th Jun 2023
Ironwood's drug Linzess is seeing its sales start to plateau. It could get an expanded indication for Linzess that delays a decline in revenue.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of VectivBio Ho
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of VectivBio Ho
Why Shares of VectivBio Holding Are Up Today
12:02pm, Monday, 22'nd May 2023
Ironwood Pharmaceuticals' buyout deal is worth $1 billion. The attraction was VectivBio's late-stage therapy, apraglutide.
VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion
09:43am, Monday, 22'nd May 2023
Ironwood Pharmaceuticals said Monday it will buy VectivBio for $1 billion. The deal sent VECT stock flying, while IRWD stock skidded.
VECT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of VectivBio Holding AG Is Fair to Shareholders
07:56am, Monday, 22'nd May 2023
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of VectivBio Holding AG (NASDAQ: VECT) to Ironwood Pharmaceuticals, Inc. for $17.00 per shar
Ironwood Pharmaceuticals to Acquire VectivBio for About $1 Billion
07:46am, Monday, 22'nd May 2023
Ironwood Pharmaceuticals is paying $17 a share for the Swiss biotech company.
Ironwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about $1 billion
07:10am, Monday, 22'nd May 2023
Ironwood Pharmaceuticals Inc. IRWD, +2.45% said Monday it has agreed to acquire Swiss biotech VectivBio Holding AG VECT, +8.18% for $17 a share in cash, or a total of about $1 billion, net of VectivBi
BOSTON & BASEL, Switzerland--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT)
VectivBio: Swiss Company With Excellent Data, Upcoming Catalysts
08:00am, Monday, 17'th Apr 2023
VectivBio: Swiss Company With Excellent Data, Upcoming Catalysts
VectivBio to Present at the 2022 Jefferies London Healthcare Conference
08:28am, Wednesday, 09'th Nov 2022
BASEL, Switzerland, Nov. 09, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for
VectivBio Announces Date of Extraordinary General Meeting of Shareholders
10:00am, Wednesday, 12'th Oct 2022
BASEL, Switzerland, Oct. 12, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for
VectivBio Holding AG (VECT) CEO Luca Santarelli on Q4 2021 Results - Earnings Call Transcript
01:14pm, Thursday, 07'th Apr 2022
VectivBio Holding AG (VECT) CEO Luca Santarelli on Q4 2021 Results - Earnings Call Transcript
